Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GE Healthcare Cell Proliferation Kit, BioTrak™ ELISA Kit and Components Available on GSA/VA Contract for Federal Government customers only.

Provides a precise, fast and simple colorimetric assay to quantitate proliferating cells cultured in a 96 well microplate

Manufacturer:  GE Healthcare RPN201

 View more versions of this product

Catalog No. 45-000-836


  Check Availability
Add to cart

Specifications

Description

  • Recommended cell number: 10e6-10e7 cells/mL (Cell proliferation kit) 10e2 cells/well-10e5 cells/well (Biotrak ELISA kit)
  • Required time: 2-3 hour post-labeling (labeling 1-2 hours)
  • Antibody and labeling reagent available separately for ELISA and ICC systems
  • Suitable for in vivo and in vitro tissue labeling in addition to cultured cells (ELISA format)
  • Non radioactive protocols provide sensitivity comparable to autoradiographic methods
  • Cell proliferation kit avoids the need to chemically denature DNA. Cellular morphology is preserved allowing multiple labeling experiments
  • 5-fluoro-2'-deoxyuridine is used to inhibit thymidilate synthetase increasing BrdU incorporation

When ordering the Cell Proliferation Kit (RPN20), you must also order DAB REAGENT OF RPN20/RPN1174 (RPNK8888)

Description & Specifications

Specifications

Immunocytochemistry
10mL of Aqueous 5-bromo-2'-deoxyuridine and 5-fluoro-2'-deoxyuridine
10mL
2° to 8°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit